Fronte
Posted - 47 minutes ago
$SWTX added and ready to add more
Night_Owl_Biotech
Posted - 2 hours ago
The $XBI has technically crashed now that it is down 20% over the last 36 trading days (intra-day). We ran a history of the XBI since launched & noted several other periods where crashes in the XBI have been much worse. Unfortunately, we have no idea how the XBI will trade in the near-term. However, it may, again may, be a better time for patient long-term investors to buy quality commercial-stage biopharmas today than it was 36 trading days ago. Of course these so called quality stocks may fall another 20% over the next 2 months for all we know. $SWTX $IMCR $BCRX $MDGL This is not investment advice. As always, the data on the attachment may be inaccurate. You can lose your entire investment buying biopharma stocks.
Fronte
Posted - 8 hours ago
$SWTX
Tzip
Posted - 22 hours ago
$SWTX this has been utter garbage along with most bio's but still holding for the bo; hopefully have a nice earnings call.
patten1962
Posted - 1 day ago
$SWTX Even though it's down a little bit today, I do believe we will start to see a little run going into earnings. I believe that people will be excited about one full quarter with a new drug.
patten1962
Posted - 1 day ago
$SWTX Yesterday After-Hours, 1 share drops the price! 🤣🤣🤣🤣
Stock_Titan
Posted - 1 day ago
$SWTX SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
https://www.stocktitan.net/news/SWTX/spring-works-therapeutics-to-report-first-quarter-2024-financial-53sa2holo4ea.html
Night_Owl_Biotech
Posted - 4 days ago
The attachment notes the share price activity over the last 6 weeks of the 5 (relatively) recent commercial-stage oncology focused biopharmas with FDA approved cancer therapies anticipated to do at least $1B (or very close to $1B/year). All 5 are down 10-20% more or less consistent with the change in the XBI. It's our experience oncology focused biopharmas are more often acquired than non. Of course this does not mean it will be the case in the future. As always, our data could be wrong. This is not investment advice. $IMCR $SWTX $DAWN $DCPH $XBI
Okadarlan
Posted - 4 days ago
$SWTX not selling till its below 30.
RonIsWrong
Posted - 5 days ago
$ALPN $XBI $MRUS $SWTX $FUSN FUSN ☑️ ALPN ☑️ SNDX _?_ SWTX - bring it !! KRYS _?_
Fronte
Posted - 1 week ago
$SWTX still boring . But not selling . See you in may …. They have also other drug in pipeline and Europe approval submitted. Forget about Bo any soon . Cheers and good luck
WSRX
Posted - 1 week ago
$SWTX can’t wait to see them blow out sales expectations for Q1
patten1962
Posted - 1 week ago
$SWTX @MaxDanger @rooksleanne Good morning, look at the spread this morning on the Nasdaq.
Bid $27.45
Ask $56.10
Trust what you know. Earnings come soon. We will be back over $50.
Institutions still at 103%
patten1962
Posted - 1 week ago
$SWTX Coming back a little.
geothug
Posted - 1 week ago
$SWTX
Bornjever
Posted - 1 week ago
$SWTX so the big boys like Black Rock etc have over 3 billion invested in this so believe they expect some fat earnings and not at once but every quarter more and more and by the way almost 42,000 buyers and less than 2,000 sellers with earnings coming beginning of May
Fronte
Posted - 1 week ago
$SWTX so they knew cpi and let it go. When we will see decent volumes it would mean bottom is in . Maybe it was today already. Good luck
Bornjever
Posted - 1 week ago
$SWTX agreed this is a cure for one type of cancer and seems like so many are getting beaten up but our earnings coming up on May 1 should give us a taste of what we can expect
patten1962
Posted - 1 week ago
$SWTX Don't look at pre market here. All bs. Not even one share is sold.
patten1962
Posted - 1 week ago
$SWTX Just checked the Nasdaq site. Short shares 10.5m
Institutions still 103%
Earnings still may 1st.
Fronte
Posted - 1 week ago
$SWTX bad cpi = lot of Vaseline needed. Finger crossed
Bornjever
Posted - 1 week ago
$SWTX this company has earnings coming that will show the sales of a drug that can completely cure those who normally would have died from soft cell cancer and this is a fairly rare disease but if you have it this is a cure and our sales and profits are going to be much better than ever and the next quarter is going to be better on May 1 we will get good news
Fronte
Posted - 1 week ago
$SWTX now is becoming very boring . Bad cpi and we see a 3 at the beginning
patten1962
Posted - 1 week ago
$SWTX If any of you investors are on Twitter, please look for #. Spring works therapeutics. I will usually post something there. But I don't have enough followers. The more we get the word out on this stock, more buyers will get, and that'll put more pressure on the shorts.
patten1962
Posted - 1 week ago
$SWTX I have not seen pre market action in a while
tedevan
Posted - 1 week ago
$SNDX $BPMC $IOVA $SWTX $IMCR
patten1962
Posted - 1 week ago
$SWTX About 4 weeks to next earnings. I will hold till then. Short will do what they do. I will buy more! We all should buy a little everyday to make the shorts work!!!
Night_Owl_Biotech
Posted - 1 week ago
With Morgan Stanley in the news again about M&A & bio valuations with rate cuts, attached is a list of all of the commercial-stage oncology focused bios that have been acquired or merged/spun-off showing the # of months the LLE took place after its last FDA approval (sorted low to high). On the right side please find the remaining independent commercial-stage oncology focused biopharmas noting how long it has been since FDA approval. Be careful, our date info may not be perfect with those that have/had multiple FDA approvals. If commercial-stage oncology focused M&A is expected to be hot this year (versus clinical-stage) then it appears there are only so many with market caps of less than $10B & a recent approval (enough to drive significant growth to an acquirer). Obvious candidates would be $SWTX $IOVA $IMCR $SNDX & $BPMC
Fronte
Posted - 1 week ago
$SWTX these are all Bo buyers getting out . Hopefully they will be done soon
NotOfTheBody
Posted - 2 weeks ago
$SWTX Stock is a stone's throw away from entering oversold territory on the RSI 14. Already there on the RSI 9 at 27 and the Willams R% (14) at -94. Good time to add more if you can imo. Added another 500 at $43.75.